Demyelinating Disease following Anti-TNFa Treatment: A Causal or Coincidental Association? Report of Four Cases and Review of the Literature

<table>(a) Axial T2- and (b) T1-weighted brain MRI of the second patient showing subcortical hyperintense lesions, one with contrast enhancement (black arrows). (d) and (e) Sagittal T1 weighted with gadolinium brain MRI images showing enhanced corpus callosum lesions (black arrows). (c) Sagittal and (f) axial T2-weighted cervical spine MRI showing one hyperintense lesion (red arrows) on level C7-T1. </table>

Case Reports in Neurological Medicine

fig2

Figure 2

Figure 2: Demyelinating Disease following Anti-TNFa Treatment: A Causal or Coincidental Association? Report of Four Cases and Review of the Literature 

Figure 2 | Demyelinating Disease following Anti-TNFa Treatment: A Causal or Coincidental Association? Report of Four Cases and Review of the Literature 